Pages that link to "Q42995214"
Jump to navigation
Jump to search
The following pages link to Cardiometabolic effects of rosiglitazone in patients with type 2 diabetes and coronary artery bypass grafts: A randomized placebo-controlled clinical trial (Q42995214):
Displaying 13 items.
- PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty (Q27024799) (← links)
- The current role of thiazolidinediones in diabetes management (Q30250347) (← links)
- Dietary intervention induces flow of changes within biomarkers of lipids, inflammation, liver enzymes, and glycemic control (Q33984352) (← links)
- Effects of thiazolidinedione therapy on inflammatory markers of type 2 diabetes: a meta-analysis of randomized controlled trials (Q35510830) (← links)
- The effects of rosiglitazone on inflammatory biomarkers and adipokines in diabetic, hypertensive patients (Q36768458) (← links)
- The impacts of thiazolidinediones on circulating C-reactive protein levels in different diseases: A meta-analysis (Q42868308) (← links)
- Impact of visceral obesity on cardiac parasympathetic activity in type 2 diabetics after coronary artery bypass graft surgery (Q45020795) (← links)
- Impact of rosiglitazone on body composition, hepatic fat, fatty acids, adipokines and glucose in persons with impaired fasting glucose or impaired glucose tolerance: a sub-study of the DREAM trial (Q51321569) (← links)
- Normalization of visceral adiposity is required to normalize plasma apolipoprotein B levels in response to a healthy eating/physical activity lifestyle modification program in viscerally obese men (Q51361310) (← links)
- Determinants of evolving metabolic and cardiovascular benefit/risk profiles of rosiglitazone therapy during the natural history of diabetes: molecular mechanisms in the context of integrated pathophysiology (Q58229736) (← links)
- Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence (Q90722135) (← links)
- Obesity and its cardiovascular effects (Q91331127) (← links)
- Metabolic effects of antihyperglycemic agents and mortality: meta-analysis of randomized controlled trials (Q98177180) (← links)